Your browser doesn't support javascript.
loading
Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposure.
Pizuorno Machado, Antonio; Shatila, Malek; Liu, Cynthia; Lu, Yang; Altan, Mehmet; Glitza Oliva, Isabella C; Zhao, Dan; Zhang, Hao Chi; Thomas, Anusha; Wang, Yinghong.
Afiliación
  • Pizuorno Machado A; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
  • Shatila M; Department of Gastroenterology, Hepatology and Nutrition, Unit 1466, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
  • Liu C; Department of Internal Medicine, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Lu Y; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Altan M; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Glitza Oliva IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Zhao D; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Zhang HC; Department of Gastroenterology, Hepatology and Nutrition, Unit 1466, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
  • Thomas A; Department of Gastroenterology, Hepatology and Nutrition, Unit 1466, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
  • Wang Y; Department of Gastroenterology, Hepatology and Nutrition, Unit 1466, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. ywang59@mdanderson.org.
J Cancer Res Clin Oncol ; 149(9): 5989-5998, 2023 Aug.
Article en En | MEDLINE | ID: mdl-36611109

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Perforación Intestinal / Neoplasias Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Perforación Intestinal / Neoplasias Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...